SCHEMBL5352341

SCHEMBL5352341

CS(=O)(=O)Nc1ccc(NC(=O)CC(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
KEAP1 Q14145 1/20 0.52
KDM4E B2RXH2 3/20 0.52
HPGD P15428 3/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 2/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
RECQL P46063 1/20 0.49
POLB P06746 1/20 0.48
TSHR P16473 1/20 0.47
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA4 P22748 2/20 0.46
CA7 P43166 1/20 0.46
ATM Q13315 1/20 0.46
PGR P06401 1/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11638463 0.82 MEN1 (0.52) MEN1KMT2AKEAP1KDM4EHPGD
SCHEMBL4577565 0.82 PRMT1 (0.64) MEN1KMT2AKDM4EHPGDLMNA
SCHEMBL19329702 0.81 KEAP1 (0.59) KEAP1KDM4EHPGDLMNAALDH1A1
SCHEMBL5345636 0.80 KMT2A (0.59) MEN1KMT2AKDM4EHPGDLMNA
SCHEMBL25990039 0.79 KDM1A (0.56) MEN1KMT2ALMNAHTTPOLB
SCHEMBL4577014 0.78 KEAP1 (0.55) KEAP1KDM4EHPGDLMNAALDH1A1
SCHEMBL10868056 0.77 HPGD (0.67) MEN1KMT2AKEAP1KDM4EHPGD
SCHEMBL14992916 0.77 POLB (0.55) MEN1KMT2AHPGDALDH1A1POLB
SCHEMBL8141141 0.77 POLB (0.80) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL10426110 0.77 ALDH1A1 (0.63) MEN1KMT2AKDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7160902-B2 Amide derivatives and methods of their use ADOLOR CORPORATION (US) 2007-01-09 US disclosed
WO-2005049564-A1 AMIDE DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORPORATION (US) 2005-06-02 WO disclosed
US-20050107355-A1 Amide derivatives and methods of their use CUBIST PHARMACEUTICALS, INC. 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107355-A1 Amide derivatives and methods of their use HRH2, SLC10A2, ALPI MEN1 4308/4885KMT2A 3693/4885KEAP1 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.